Clinical Trials
3 trialsNCT05001282 2024-08-07
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)
Elucida Oncology
Phase 1/2 Terminated
NCT03029585 2021-04-27
Phase II Study of Intraperitoneal NanoPacĀ® in Patients With Ovarian Cancer
NanOlogy, LLC
Phase 2 Terminated
NCT01016054 2013-02-27
A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer
Astellas Pharma Inc
Phase 1 Terminated